Pyridyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides

US9556121B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9556121-B2
Application numberUS-201314441554-A
CountryUS
Kind codeB2
Filing dateNov 8, 2013
Priority dateNov 13, 2012
Publication dateJan 31, 2017
Grant dateJan 31, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application relates to novel pyridyloxyalkylcarboxamides of the formula (I) and to their use as endoparasiticides against endoparasites in animals or humans, and to their use as nematicides for controlling phytopathogenic nematodes, and furthermore to endoparasiticides and nematicides comprising pyridyloxyalkylcarboxamides.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for controlling endoparasites selected from the group consisting of helminths, nematodes, Pentastoma, and Acanthocephala in animals or humans comprising administering prophylactically and/or therapeutically to the animal or human a compound to thereby control said endoparasite, wherein the compound is a compound of formula (I) where Q represents the structural elements below, where n for each Q is in each case as defined below: Y represents hydrogen or represents optionally mono- or poly-M 2 -substituted (C 1 -C 10 )-alkyl, (C 2 -C 10 )-alkenyl, (C 2 -C 10 )-alkynyl, (C 1 -C 10 )-haloalkyl, (C 2 -C 10 )-haloalkenyl, (C 2 -C 10 )-haloalkynyl, (C 1 -C 10 )-alkoxy, (C 2 -C 10 )-alkenyloxy, (C 3 -C 10 )-alkynyloxy, (C 3 -C 14 )-cycloalkyl-(C 1 -C 10 )-alkyl or represents an optionally mono- or poly-M 2 -substituted 3- to 14-membered cyclic group; W represents oxygen or sulphur; L 2 represents —C(R 21 , R 22 )—; L 3 represents —C(R 31 , R 32 )—; M 1 , M 2 and M 3 each independently of one another represent hydrogen, halogen, cyano, nitro, OH, (C 1 -C 10 )-alkyl, (C 1 -C 10 )-haloalkoxy, (C 1 -C 10 )-alkoxy, (C 1 -C 10 )-haloalkoxy, (C 1 -C 10 )-alkylthio, (C 1 -C 10 )haloalkylthio, (C 1 -C 10 )-alkylsulphonyl, (C 1 -C 10 )-haloalkylsulphonyl, (C 1 -C 10 )-alkylsulphanyl, (C 1 -C 10 )-haloalkylsulphanyl or (3- to 14-membered cyclic group)-O—; M 4 represents hydrogen, halogen, cyano, nitro, OH, (C 1 -C 10 )-alkyl, (C 1 -C 10 )-haloalkyl, (C 1 -C 10 )-alkoxy, (C 1 -C 10 )-haloalkoxy, (C 1 -C 10 )-alkylthio, (C 1 -C 10 )-haloalkylthio, (C 1 -C 10 )-alkylsulphonyl, (C 1 -C 10 )-haloalkylsulphonyl, (C 1 -C 10 )-alkylsulphanyl, (C 1 -C 10 )-haloalkylsulphanyl or (3- to 14-membered cyclic group)-O—; k represents 1, 2 or 3; R 21 , R 22 each independently of one another represent hydrogen, halogen or optionally mono- or poly-M 2 -substituted (C 1 -C 10 )-alkyl, (C 2 -C 10 )-alkenyl, (C 2 -C 10 )-alkynyl, (C 1 -C 10 )-haloalkyl, (C 2 -C 10 )-haloalkenyl, (C 2 -C 10 )-haloalkynyl, (C 1 -C 10 )-alkoxy, (C 1 -C 10 )-haloalkoxy, (C 2 -C 10 )-alkenyloxy, (C 3 -C 10 )-alkynyloxy, (C 3 -C 14 )-cycloalkyl-(C 1 -C 10 )-alkyl or represent an optionally mono- or poly-M 2 -substituted 3- to 14-membered cyclic group; or R 21 , R 22 together represent an optionally mono- or poly-M 2 -substituted spiro-attached 3- to 14-membered carbo- or 3- to 10-membered heterocyclic group; R 31 , R 32 each independently of one another represent hydrogen, halogen or optionally mono- or poly-M 2 -substituted (C 1 -C 10 )-alkyl, (C 2 -C 10 )-alkenyl, (C 2 -C 10 )-alkynyl, (C 1 -C 10 )-haloalkyl, (C 2 -C 10 )-haloalkenyl, (C 2 -C 10 )-haloalkynyl, (C 3 -C 14 )-cycloalkyl-(C 1 -C 10 )-alkyl or represent an optionally mono- or poly-M 2 -substituted 3- to 14-membered cyclic group; R 31 , R 32 together represent an optionally mono- or poly-M 5 -substituted spiro-attached 3- to 14-membered carbo- or 3- to 10-membered heterocyclic group; M 5 in each case independently of the others represents halogen, formyl, cyano, nitro, (C 1 -C 10 )-alkyl, (C 1 -C 10 )-haloalkyl, (C 2 -C 10 )-alkenyl, (C 2 -C 10 )-haloalkenyl, (C 2 -C 10 )-alkynyl, (C 2 -C 10 )-haloalkynyl, (C 1 -C 10 )-alkoxy, (C 1 -C 10 )-haloalkoxy, (C 2 -C 10 )-alkenyloxy, (C 2 -C 10 )-haloalkenyloxy, (C 3 -C 10 )-alkynyloxy, (C 3 -C 10 )-haloalkynyloxy, (C 1 -C 10 )-alkylthio, (C 1 -C 10 )-haloalkylthio, (C 2 -C 10 )-alkenylthio, (C 2 -C 10 )-haloalkenylthio, (C 3 -C 10 )-alkynylthio, (C 3 -C 10 )-haloalkynylthio, (C 1 -C 10 )-alkylsulphonyl, (C 1 -C 10 )-haloalkylsulphonyl, (C 2 -C 10 )-alkenylsulphonyl, (C 2 -C 10 )-haloalkenylsulphonyl, (C 3 -C 10 )-alkynylsulphonyl, (C 3 -C 10 )-haloalkynylsulphonyl, (C 1 -C 10 )-alkylsulphanyl, (C 1 -C 10 )-haloalkylsulphanyl, (C 2 -C 10 )-alkenylsulphanyl, (C 2 -C 10 )-haloalkenylsulphanyl, (C 3 -C 10 )-alkynylsulphanyl, (C 3 -C 10 )-haloalkynylsulphanyl, (C 1 -C 10 )-alkylcarbonyl, (C 1 -C 10 )-haloalkylcarbonyl, (C 2 -C 10 )-alkenylcarbonyl, (C 2 -C 10 )-haloalkenylcarbonyl, (C 2 -C 10 )-alkynylcarbonyl, (C 2 -C 10 )-haloalkynylcarbonyl, (C 1 -C 10 )-alkoxycarbonyl, (C 1 -C 10 )-haloalkoxycarbonyl, (C 2 -C 10 )-alkenyloxycarbonyl, (C 2 -C 10 )-haloalkenyloxycarbonyl, (C 3 -C 10 )-alkynyloxycarbonyl, (C 3 -C 10 )-haloalkynyloxycarbonyl, (C 1 -C 10 )-alkylcarbonyloxy, (C 1 -C 10 )-haloalkylcarbonyloxy, (C 2 -C 10 )-alkenylcarbonyloxy, (C 2 -C 10 )-haloalkenylcarbonyloxy, (C 2 -C 10 )-alkynylcarbonyloxy, (C 2 -C 10 )-haloalkynylcarbonyloxy, a 3- to 14-membered cyclic group; and/or a salt, N-oxide and/or tautomeric form of a compound of the formula (I), except for the compounds N-[2-(pyridin-2-yloxy)ethyl]-4-(trifluoromethyl)nicotinamide: and 4-(trifluoromethyl)-N-(2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}ethyl)nicotinamide: 2. A method according to claim 1 where Q represents the structural elements below, where n for each Q is in each case as defined below: Y represents hydrogen or represents optionally mono- or poly-M 2 -substituted (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 1 -C 6 )-haloalkyl, (C 2 -C 6 )-haloalkenyl, (C 2 -C 6 )-haloalkynyl, (C 1 -C 6 )-alkoxy, (C 2 -C 6 )-alkenyloxy, (C 3 -C 6 )-alkynyloxy, (C 3 -C 10 )-cycloalkyl-(C 1 -C 6 )-alkyl or represents an optionally mono- or poly-M 2 -substituted 3- to 10-membered cyclic group; W represents oxygen, M 1 , M 2 and M 3 each independently of one another represent hydrogen, halogen, cyano, nitro, OH, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-haloalkyl, (C 1 -C 6 )-alkoxy, (C 1 -C 6 )-haloalkoxy, (C 1 -C 6 )-alkylthio, (C 1 -C 6 )-haloalkylthio, (C 1 -C 6 )-alkylsulphonyl, (C 1 -C 6 )-haloalkylsulphonyl, (C 1 -C 6 )-alkylsulphanyl, (C 1 -C 6 )-haloalkylsulphanyl, (C 3 -C 14 )-cycloalkyl-O—, (C 3 -C 14 )-cycloalkenyl-O—, (C 6 -C 14 )-aryl-O—, halogenated (C 3 -C 14 )-cycloalkyl-O—, halogenated (C 3 -C 14 )-cycloalkenyl-O—, halogenated (C 6 -C 14 )-aryl-O—, where, if Q corresponds to Q 11 , M 3 is not (C 1 -C 4 )-haloalkyl in position 4 at the pyridyl; M 4 represents hydrogen, halogen, cyano, nitro, OH, (C 1 -C 6 )-alkyl, (C 1 -C 6 )-haloalkyl, (C 1 -C 6 )-alkoxy, (C 1 -C 6 )-haloalkoxy, (C 1 -C 6 )-alkylthio, (C 1 -C 6 )-haloalkylthio, (C 1 -C 6 )-alkyl sulphonyl, (C 1 -C 6 )-haloalkylsulphonyl, (C 1 -C 6 )-alkylsulphanyl, (C 1 -C 6 )-haloalkylsulphanyl, (C 3 -C 14 )-cycloalkyl-O—, (C 3 -C 14 )-cycloalkenyl-O—, (C 6 -C 14 )-aryl-O—, halogenated (C 3 -C 14 )-cycloalkyl-O—, halogenated (C 3 -C 14 )-cycloalkenyl-O—, halogenated (C 6 -C 14 )-aryl-O—, where, if Q corresponds to Q 10 , M 4 is not (C 1 -C 4 )-haloalkyl; k represents for 2; R 21 , R 22 each independently of one another represent hydrogen, fluorine or optionally mono- or poly-M 2 -substituted (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 1 -C 6 )-haloalkyl, (C 2 -C 6 )-haloalkenyl, (C 2 -C 6 )-haloalkynyl, (C 1 -C 6 )-alkoxy, (C 1 -C 6 )-haloalkoxy, (C 2 -C 6 )-alkenyloxy, (C 3 -C 6 )-alkynyloxy, (C 3 -C 6 )-cycloalkyl-(C 1 -C 6 )-alkyl or represent an optionally mono- or poly-M 2 -substituted (C 3 -C 14 )-carbocyclic group; or

Assignees

Inventors

Classifications

  • linked by a chain containing hetero atoms as chain links · CPC title

  • Nitriles · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

  • Antiparasitic agents · CPC title

  • 1,2-Diazoles; Hydrogenated 1,2-diazoles · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9556121B2 cover?
The present application relates to novel pyridyloxyalkylcarboxamides of the formula (I) and to their use as endoparasiticides against endoparasites in animals or humans, and to their use as nematicides for controlling phytopathogenic nematodes, and furthermore to endoparasiticides and nematicides comprising pyridyloxyalkylcarboxamides.
Who is the assignee on this patent?
Bayer Cropscience Ag
What technology area does this patent fall under?
Primary CPC classification C07D213/64. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).